Dr. Rick Bright To File Whistle Blower’s Complaint

0
1170
www.youtube.com

Lawyers for ousted U.S. health official say he will file whistleblower complaint

Reuters: Reporting by Steve Holland; Writing by Makini Brice; Editing by Doina Chiacu and Tom Brown

WASHINGTON (Reuters) – Lawyers for the ousted director of a U.S. agency responsible for the development of drugs to fight the COVID-19 pandemic said on Thursday he will file a whistleblower’s complaint with two government offices over his reassignment.

Rick Bright said on Wednesday he was replaced as director of the Biomedical Advanced Research and Development Authority, or BARDA, because he resisted the Trump administration’s efforts to push hydroxychloroquine and the related chloroquine as cures for COVID-19, the respiratory illness caused by the coronavirus.

U.S. President Donald Trump has repeatedly touted the malaria drugs as a treatment for coronavirus though few studies suggest a possible benefit.

“In our filing we will make clear that Dr. Bright was sidelined for one reason only — because he resisted efforts to provide unfettered access to potentially dangerous drugs, including chloroquine, a drug promoted by the administration as a panacea, but which is untested and possibly deadly when used improperly,” his lawyers said in a statement.

His lawyers said they will file the complaint with the Office of Special Counsel and the Department of Health and Human Services’ Inspector General.

Read More:

ATTENTION READERS
Due to the nature of independent content, VT cannot guarantee content validity.
We ask you to Read Our Content Policy so a clear comprehension of VT's independent non-censored media is understood and given its proper place in the world of news, opinion and media.

All content is owned by author exclusively. Expressed opinions are NOT necessarily the views of VT, other authors, affiliates, advertisers, sponsors, partners or technicians. Some content may be satirical in nature. All images within are full responsibility of author and NOT VT.

About VT - Read Full Policy Notice - Comment Policy